Viewing Study NCT05345002


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT05345002
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2022-04-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Sponsor: Stephen Bagley, MD, MSCE
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module